These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16787368)

  • 21. A fluorescent hPept1 transporter substrate for uptake screening.
    Landowski CP; Han HK; Lee KD; Amidon GL
    Pharm Res; 2003 Nov; 20(11):1738-45. PubMed ID: 14661916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeation.
    Gudmundsson OS; Nimkar K; Gangwar S; Siahaan T; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):16-23. PubMed ID: 9950273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
    Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
    Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.
    Bak A; Gudmundsson OS; Friis GJ; Siahaan TJ; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):24-9. PubMed ID: 9950274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
    Horie K; Tang F; Borchardt RT
    Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for two different broad-specificity oligopeptide transporters in intestinal cell line Caco-2 and colonic cell line CCD841.
    Chothe P; Singh N; Ganapathy V
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1260-9. PubMed ID: 21307350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
    Lalloo AK; Luo FR; Guo A; Paranjpe PV; Lee SH; Vyas V; Rubin E; Sinko PJ
    BMC Med; 2004 May; 2():16. PubMed ID: 15125776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
    Nielsen CU; Brodin B
    Curr Drug Targets; 2003 Jul; 4(5):373-88. PubMed ID: 12816347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.
    Li Q; Sai Y; Kato Y; Tamai I; Tsuji A
    Pharm Res; 2003 Aug; 20(8):1119-24. PubMed ID: 12948007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport characteristics of peptides and peptidomimetics: II. Hydroxyethylamine bioisostere-containing peptidomimetics as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.
    Gao J; Winslow SL; Vander Velde D; Aubé J; Borchardt RT
    J Pept Res; 2001 May; 57(5):361-73. PubMed ID: 11350596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
    Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT
    Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers.
    Lang VB; Langguth P; Ottiger C; Wunderli-Allenspach H; Rognan D; Rothen-Rutishauser B; Perriard JC; Lang S; Biber J; Merkle HP
    J Pharm Sci; 1997 Jul; 86(7):846-53. PubMed ID: 9232527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
    Tamura K; Lee CP; Smith PL; Borchardt RT
    Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
    Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
    J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
    Irie M; Terada T; Sawada K; Saito H; Inui K
    J Pharmacol Exp Ther; 2001 Aug; 298(2):711-7. PubMed ID: 11454935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.